The economics of the NHS cancer drugs fund

被引：0
|
作者：
Alan Maynard
Karen Bloor
机构：
[1] University of York,Department of Health Sciences
来源：
Applied Health Economics and Health Policy | 2011年 / 9卷 / 3期
关键词：
Multiple Sclerosis; Political Advantage; Cancer Drug Fund; Maximum Health Gain; Preferential Funding;
D O I：
10.2165/11585750-000000000-00000
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 138
页数：1
相关论文
共 50 条
  • [31] Where is the evidence for the existence of the Cancer Drugs Fund?
    Chamberlain, Charlotte
    Hollingworth, William
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [32] Cancer Drugs Fund requires further reform
    Grieve, Richard
    Abrams, Keith
    Claxton, Karl
    Goldacre, Ben
    James, Nicholas
    Nicholl, Jon
    Parmar, Mahesh
    Parker, Chris
    Sekhon, Jasjeet S.
    Smeeth, Liam
    Spiegelhalter, David
    Sculpher, Mark
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [33] Which way now for the Cancer Drugs Fund?
    Jack, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [34] Cancer Drugs Fund 2.0: A Missed Opportunity?
    Christopher McCabe
    Ash Paul
    Greg Fell
    Mike Paulden
    PharmacoEconomics, 2016, 34 : 629 - 633
  • [35] Cutbacks at England's Cancer Drugs Fund
    不详
    CANCER DISCOVERY, 2015, 5 (04) : 338 - 339
  • [36] THE CANCER DRUGS FUND: THE EVOLVING ASSESSMENT PROCESS
    Carroll, M., V
    Satherley, A.
    Miller, P. S.
    VALUE IN HEALTH, 2016, 19 (07) : A757 - A757
  • [37] Cancer Drugs Fund 2.0: A Missed Opportunity?
    McCabe, Christopher
    Paul, Ash
    Fell, Greg
    Paulden, Mike
    PHARMACOECONOMICS, 2016, 34 (07) : 629 - 633
  • [38] Tax the rich to fund the NHS
    Wortley, Pam M.
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [39] A mixed methods study on the prioritisation of cancer and access to cancer drugs: the Cancer Drugs Fund in England
    Chamberlain, Charlotte
    Owen-Smith, Amanda
    Donovan, Jenny L.
    Hounsome, Luke
    Collin, Simon M.
    Hollingworth, William
    LANCET, 2015, 386 : S17 - S17
  • [40] NICE recommends dropping two drugs from Cancer Drugs Fund
    Hawkes, Nigel
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
12345